Stay updated on AAV2/6 Gene Therapy SB-525 in Severe Hemophilia A Clinical Trial
Sign up to get notified when there's something new on the AAV2/6 Gene Therapy SB-525 in Severe Hemophilia A Clinical Trial page.
Latest updates to the AAV2/6 Gene Therapy SB-525 in Severe Hemophilia A Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedPubMed publications section description updated to indicate entries are automatically filled from PubMed and may not all pertain to the study. The revision label was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%
- Check17 days agoChange DetectedRemoval of the government funding status notice; this change does not affect study details, eligibility criteria, or other user-facing information on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check31 days agoChange DetectedAdded results-related dates and QC status to the study record, including Results First Submitted, Results First Posted with QC Comments, and the estimated Results First Posted date. This update clarifies when results are available and shows QC milestones for the study record.SummaryDifference0.4%
- Check60 days agoChange DetectedAdded comprehensive results measures, timing, and reporting details, plus a government-operating-status note; removed a prior, shorter adverse-events results item.SummaryDifference100%
- Check67 days agoChange DetectedStandardize disease naming and update version to v3.1.0.SummaryDifference0.2%
- Check81 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.3%
Stay in the know with updates to AAV2/6 Gene Therapy SB-525 in Severe Hemophilia A Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AAV2/6 Gene Therapy SB-525 in Severe Hemophilia A Clinical Trial page.